India to Ethiopia: Insulin Export Trade Route

The India to Ethiopia Insulin corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $5.0M USD. The route is dominated by M. J. BIOPHARM PRIVATE LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's insulin manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $105.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with insulin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 26.0%, placing it at rank #12 among India's top insulin export destinations globally.

On the import side, key buyers of Indian insulin in Ethiopia include COMMERCIAL BANK OF ETHIOPIA, TO THE ORDER , TO and 4 others. COMMERCIAL BANK OF ETHIOPIA is the single largest importer with 13 shipments valued at $4.9M USD.

India's insulin exports to Ethiopia are driven primarily by a handful of large-scale manufacturers. M. J. BIOPHARM PRIVATE LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Ethiopia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — M. J. BIOPHARM PRIVATE LIMITED, M J BIOPHARM PRIVATE LIMITED, S HIMATLAL & CO — together account for 99% of total trade value on this route. The average shipment value of $105.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as biosulin n insulin inj.isophane ph.eur.100 iu/ml,10 ml human insulin inj.100 iu/ml,10 ml vials 638209 packs and biosulin 30/70 insulin inj.biphasic isop, suggesting that buyers in Ethiopia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, COMMERCIAL BANK OF ETHIOPIA is the largest importer with 13 shipments worth $4.9M USD — representing 99% of all insulin imports from India on this route. A total of 7 buyers are active on this corridor.